USD 3.32
(-7.78%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 1.98 Billion USD | 13.61% |
2022 | 393.65 Million USD | -29.43% |
2021 | 557.81 Million USD | 218.52% |
2020 | 175.12 Million USD | -10.54% |
2019 | 195.76 Million USD | -58.87% |
2018 | 475.99 Million USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 104.11 Million USD | -5.87% |
2024 Q2 | 100.25 Million USD | -3.7% |
2023 Q3 | 103.26 Million USD | 2.51% |
2023 Q2 | 100.73 Million USD | -21.24% |
2023 FY | 447.23 Million USD | 13.61% |
2023 Q1 | 127.89 Million USD | 13.87% |
2023 Q4 | 110.6 Million USD | 7.11% |
2022 Q3 | 90.93 Million USD | 0.32% |
2022 Q2 | 90.64 Million USD | -9.32% |
2022 Q1 | 99.95 Million USD | -43.49% |
2022 Q4 | 112.3 Million USD | 23.51% |
2022 FY | 393.65 Million USD | -29.43% |
2021 Q1 | 104.98 Million USD | 94.65% |
2021 FY | 557.81 Million USD | 218.52% |
2021 Q4 | 176.89 Million USD | 26.36% |
2021 Q3 | 139.99 Million USD | 3.08% |
2021 Q2 | 135.81 Million USD | 29.37% |
2020 Q3 | 45.84 Million USD | 55.16% |
2020 Q2 | 29.54 Million USD | -35.5% |
2020 Q1 | 45.8 Million USD | 259709.43% |
2020 FY | 175.12 Million USD | -10.54% |
2020 Q4 | 53.93 Million USD | 17.65% |
2019 Q2 | 230.52 Million USD | 0.0% |
2019 Q4 | 17.63 Thousand USD | -99.99% |
2019 Q3 | 162.56 Million USD | -29.48% |
2019 Q1 | 230.52 Million USD | 0.0% |
2019 FY | 195.76 Million USD | -58.87% |
2018 FY | 475.99 Million USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Alignment Healthcare, Inc. | 328.84 Million USD | -503.656% |
Marpai, Inc. | 35.39 Million USD | -5508.906% |
NewGenIvf Group Limited | 2.52 Million USD | -78624.024% |